Home / Inspections / 1202871

FDA Inspection 1202871 — ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH

ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH — FEI 3004849998

The FDA completed an inspection of ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH on March 17, 2023 in Radeberg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 17, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Radeberg (Germany)

Facility

Other inspections at this facility

  • 1234443 (VAI Thu Sep 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1035733 (NAI Fri Sep 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 926013 (NAI Thu Apr 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 793984 (VAI Thu Jul 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources